Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices

Glycobiology

Volumn 18, Issue 9, 2008, Pages 735-744

  Hirashima, Mitsuomi ^a   Nagahara, Keiko ^a   Oomizu, Souichi ^a   Katoh, Shigeki ^a   Nishi, Nozomu ^b   Takeshita, Keisuke ^c   Niki, Toshiro ^c   Tominaga, Akira ^d   Yamauchi, Akira ^a   Nabumoto, Atsuya ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c GalPharma Co Ltd   (Japan)

^d KOCHI UNIVERSITY   (Japan)

Author keywords

CD44; ECM; Galectin 9; Metastasis; VLA 4

Indexed keywords

ALPHA1 INTEGRIN; ALPHA4 INTEGRIN; BETA1 INTEGRIN; CD51 ANTIGEN; ECALECTIN; HERMES ANTIGEN; HYALURONIC ACID; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN; VERY LATE ACTIVATION ANTIGEN 4; ANTINEOPLASTIC AGENT; CELL ADHESION MOLECULE; GALECTIN; GALECTIN 9, MOUSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; C57BL 6 MOUSE; CELL ADHESION; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE FUNCTION; GENE LOSS; GENE OVEREXPRESSION; GENE REPRESSION; LUNG METASTASIS; METASTASIS INHIBITION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR SUPPRESSOR GENE; VASCULAR ENDOTHELIUM; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; COLON TUMOR; DRUG EFFECT; EVALUATION; EXPERIMENTAL MELANOMA; FEMALE; LUNG TUMOR; METABOLISM; METASTASIS; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL ADHESION MOLECULES; CELL DEATH; CELL PROLIFERATION; COLONIC NEOPLASMS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FEMALE; GALECTINS; HYALURONIC ACID; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM METASTASIS; TUMOR CELLS, CULTURED;

EID: 58149126011     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwn062     Document Type: Article

References (59)

1. Algarra I, Collado A, Garcia Lora A, Garrido F. 1999. Differential effect of protein-bound polysaccharide (PSK) on survival of experimental murine tumors. J Exp Clin Cancer Res. 18:39-46.
2. Anderson AC, Anderson DE, Bregoli L, Hastings WD, Kassam N, Lei C, Chandwaskar R, Karman J, Su E, Hirashima M, et al. 2007. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science. 318:1141-1143.
3. Andre S, Kojima S, Yamazaki N, Fink C, Kaltner H, Kayser K, Gabius H.J. 1999. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity. J Cancer Res Clin Oncol. 125:461-474.
4. Baptiste TA, James A, Saria M, Ochieng J. 2007. Mechano-transduction mediated secretion and uptake of galectin-3 in breast carcinoma cells: Implications in the extracellular functions of the lectin. Exp Cell Res. 313:652-664.
5. Cardones AR, Murakami T, Hwang ST. 2003. CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin. Cancer Res. 63:6751-6757.
6. Clausse N, Van Den Brule F, Waltregny D, Gamier F, Castronovo V. 1999. Galectin-I expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion. Angiogenesis. 3:317-325.
7. Dai SY, Nakagawa R, Itoh A, Murakami H, Kashio Y, Abe H, Katoh S, Kontani K, Kihara M, Zhang SL, et al. 2005. Galectin-9 induces maturation of human monocyte-derived dendritic cells. J Immunol. 175:2974-2981.
8. Danguy A, Camby I, Kiss R. 2002. Galectins and cancer. Biochim Biophys Acta. 1572:28593.
9. Dedhar S. 1990. Integrins and tumor invasion. Bioassays. 12:583-590.
10. DeGrendele HC, Estess P, Siegelman MH. 1997. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science. 278:672-675.
11. Eccles SA, Box C, Court W. 2005. Cell migration/invasion assays and their application in cancer drug discovery. Biotechnol Annu Rev. 11:391-421.
12. Ellenrieder V, Adler G, Gress TM. 1990. Invasion and metastasis in pancreatic cancer. Ann Oncol. 10:46-50.
13. Ellerhorst J, Nguyen T, Cooper DN, Lotan D, Lotan R. 1999. Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype. Int J Oncol. 14:217-224.
14. Engbring JA, Kleinman HK. 2003. The basement membrane matrix in malignancy. J Pathol. 200:465-470.
15. Fischer C, Sanchez-Ruderisch H, Welzel M, Wiedenmann B, Sakai T, Andre S, Gabius HJ, Khachigian L, Detjen KM, Rosewicz S. 2005. Galectin-I interacts with the {alpha}5{beta} 1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J Biol Chem. 280:37266-37277.
16. Guo Y, Ma J, Wang J, Che X, Narula J, Bigby M, Wu M, Sy MS. 1994. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res. 54:1561-1565.
17. Hadari YR, Arbel-Goren R, Levy Y, Amsterdam A, Alon R, Zakut R, Zick Y. 2000. Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci. 113:2385-2397.
18. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell. 100:57-70.
19. Hirabayashi J, Hashidate T, Arata Y, Nishi N, Nakamura T, Hirashima M, Urashima T, Oka T, Futai M, Muller WE, et al. 2002. Oligosaccharide specificity of galectins: A search by frontal affinity chromatography. Biochim Biophys Acta. 1572:232-254.
20. Hsu DK, Liu FT. 2004. Regulation of cellular homeostasis by galectins. Glycoconj J. 19:507-515.
21. Hughes RC. 2001. Galectins as modulators of cell adhesion. Biochimie 83:667-676.
22. Inufusa H, Nakamura M, Adachi T, Aga M, Kurimoto M, Nakatani Y, Wakano T, Miyake M, Okuno K, Shiozaki H, et al. 2001. Role of galectin-3 in adenocarcinoma liver metastasis. Int J Oncol. 19:913-919.
23. Irie A, Yamauchi A, Kontani K, Kihara M, Liu D, Shirato Y, Seki M, Nishi N, Nakamura T, Yokomise H, et al. 2005. Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer. Clin Cancer Res. 11:2962-2968.
24. Jothy S. 2003. CD44 and its partners in metastasis. Clin Exp Metastasis. 20:195-201.
25. Kageshita T, Kashio Y, Yamauchi A, Seki M, Abedin MJ, Nishi N, Shoji H, Nakamura T, Ono T, Hirashima M. 2002. Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer. 99:809-816.
26. Kashio Y, Nakamura K, Abedin MJ, Seki M, Nishi N, Yoshida N, Nakamura T, Hirashima M. 2003. Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J Immunol. 170:3631-3636.
27. Katoh S, Ishii N, Nobumoto A, Takeshita K, Dai SY, Shinonaga R, Niki T, Nishi N, Tominaga A, Yamauchi A, et al. 2007. Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a marine model of allergic asthma. Am J Respir Crit Care Med. 176:27-35.
28. Keryer-Bibens C, Pioche-Durieu C, Villemant C, Souqure S, Nishi, N, Hirashima M, Midledorp J, Busson P. 2006. Exosomes released by EBV-infected nasopharyngeal carcinoma convey the viral latent membrane protein 1 and the immunoregulatory protein galectin-9. BMC Cancer. 6:283.
29. Khaldoyanidi SK, Glinsky VV, Sikora L, Glinskii AB, Mossine VV, Quinn TP, Glinsky GV, Sriramarao P. 2003. MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions. J Biol Chem. 278:4127-4134.
30. Kilpatrick DC. 2002. Animal lectins: A historical introduction and overview. Biochim Biophys Acta. 1572:187-197.
31. Lesley J, Hyman R, English N, Catterall JB, Turner GA. 1997. CD44 in inflammation and metastasis. Glycoconi J. 14:611-622.
32. Liu D, Liu T, Li R, Sy MS. 1998. Mechanisms regulating the binding activity of CD44 to hyaluronic acid. Front Biosci. 3:631-636.
33. Matsushita N, Nishi N, Seki M, Matsumoto R, Kuwabara I, Liu FT, Hata Y, Nakamura T, Hirashima M. 2000. Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction. J Biol Chem. 275:8355-8360.
34. Miyake K, Underhill CB, Lesley J, Kincade PW. 1990. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med. 172:69-75.
35. Mummert ME, Mummert DI, Ellinger L, Takashima A. 2003. Functional roles of hyaluronan in B16-F10 melanoma growth and experimental metastasis in mice. Mol Cancer Ther. 2:295-300.
36. Nguyen TH. 2004. Mechanisms of metastasis. Clin Dermatol. 22:209-216.
37. Nishi N, Itoh A, Fujiyama A, Yoshida N, Araya S, Hirashima M, Shoji H, Nakamura T. 2005. Development of highly stable galectins: Truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins. FEBS Lett. 579:2058-2064.
38. Nishi N, Shoji H, Seki M, Itoh A, Miyanaka H, Yuube K, Hirashima M, Nakamura T. 2003. Galectin-8 modulates neutrophil function via interaction with integrin alphaM. Glycobiology. 13:755-763.
39. O'Driscoll L, Linehan R, Liang YH, Joyce H, Oglesby I, Clynes M. 2002. Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro. Anticancer Res. 22:3117-3125.
40. Ochieng J, Leite-Browning ML, Warfield P. 1998. Regulation of cellular adhesion to extracellular matrix proteins by galectin-3. Biochem Biophys Res Commun. 246:788-791.
41. Pasco S, Ramont L, Maquart FX, Monboisse JC. 2004. Control of melanoma progression by various matrikines from basement membrane macromolecules. Crit Rev Oncol Hematol. 49:221-233.
42. Qian F, Vaux DL, Weissman IL. 1994. Expression of the integrin alpha 4 beta 1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell. 77:335-347.
43. Qian F, Zhang ZC, Wu XF, Li YP, Xu Q. 2005. Interaction between integrin alpha(5) and fibronectin is required for metastasis of B16F10 melanoma cells. Biochem Biophys Res Commun. 333:1269-1275.
44. Rubinstein N, Alvalez M, Zwimer NW, Toscano MA, Ilarregui JM, Blavo A, Mordoh J, Fainboim L, Podhajcer OL, Rabinovich GA. 2004. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege. Cancer Cell. 5:241-251.
45. Saiki I. 1997. Cell adhesion molecules and cancer metastasis. Jpn J Pharmacol. 75:215-242.
46. Sanz-Rodriguez F, Teixido J. 2001. VLA-4-dependent myeloma cell adhesion. Leuk Lymphoma. 41:239-245.
47. Seki M, Sakata K, Oomizu S, Arikawa T, Sakata A, Ueno M, Nobumoto A, Niki T, Saita N, Ito K, et al. 2007. Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum. 56:3968-3976.
48. Seki M, Oomizu S, Sakata KM, Arikawa T, Watanabe K, Ito K, Takeshita K, Niki T, Saita N, Nishi N, et al. 2008. Galectin-9 suppresses the generation of Th17, promotes the generation of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Exp Immunol. 127:78-88.
49. Sleeman JP, Arming S, Moll JF, Hekele A, Rudy W, Sherman LS, Kreil G, Ponta H, Herrlich P. 1996. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells. Cancer Res. 56:3134-3141.
50. Smolarczyk R, Cichon T, Graja K, Hucz J, Sochanik A, Szala S. 2006. Antitumor effect of RGD-4C-GG-(D)(KLAKLAK)(2) peptide inmouse B16(F10) melanoma model. Acta Biochim Pol. 53:801-805.
51. Tanikawa R, Tanikawa T, Okada Y, Nakano K, Hirashima M, Yamauchi A, Hosokawa R, Tanaka Y. 2008. Interaction of galectin-9 with lipid rafts induces osteoblast proliferation through the c-Src/ERK signaling pathway. J Bone Miner Res. 23:278-286.
52. Tomita Y, Saito K. 1995. Possible significance of VLA-4 (alpha 4 beta 1) for hematogenous metastasis of renal cell cancer. Nippon Rinsho. 53:1666-1671.
53. Wada J, Kanwar YS. 1997. Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin. J Biol Chem. 272:6078-6086.
54. Wittekind C, Neid M. 2005. Cancer invasion and metastasis. Oncology 69:14-16.
55. Zawadzki V, Perschl A, Rosel M, Hekele A, Zoller M. 1998. Blockade of metastasis formation by CD44-receptor globulin. Int J Cancer. 75:919-924.
56. Zetter BR. 1993. Adhesion molecules in tumor metastasis. Semin Cancer Biol. 4:219-229.
57. Zheng Z, Katoh S, He Q, Oritani K, Miyake K, Lesley J, Hyman R, Hamik A, Parkhouse RM, Farr AG, et al. 1995. Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J Cell Biol. 130:485-495.
58. Zhou J, Cheng Y, Ding J. 2006. The basement membrane and metastasis. Sheng Li Ke Xue Jin Zhan. 37:307-312.
59. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB, Kuchroo VK. 2005. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol. 6:1245-1252.